DIGITAL HEALTH NEWS

Welcome to #1 Digital Health News Portal.

Not a subscriber yet?
Get breaking DIGITAL HEALTH NEWS straight to your inbox. Subscribe now, it's free!

The Socio-Economic Impact of Interoperable EHR and ePrescribing Systems in Europe and Beyond

Article of the Month!

The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report
The European Commission EHR IMPACT study (EHRI) investigates the socio-economic impact of interoperable Electronic Health Record (EHR) and ePrescribing systems in Europe and beyond. Core to the project is a detailed qualitative analysis of eleven good practice cases in Europe, USA and Israel. Nine of these underwent also a quantitative evaluation of their socioeconomic impacts. Each application studied is a sustainable solution in routine operation.

This final report of the EHR IMPACT study addresses the conceptual framework for understanding and interpreting the study results, the study design and approach, and the essence of the impact analysis results.

The study takes a broad perspective of EHRs and ePrescribing. An EHR system can include parts of a comprehensive record, allows limited or extensive sharing of information, or may be part of a particular healthcare provider organisation (HPO) patient record. It usually does not contain all the health-related life-long data about people, often envisaged by grand strategies. ePrescribing is usually part of a wider health information system and often includes information on prescribing policies, clinical decision and dispensing support, advice to patients and carers, and tools to facilitate the processes and roles of each stakeholder needed to convert prescribing decisions into administered medications.

Interoperability is defined as the ability to exchange, understand and act on patient and other health information and knowledge among linguistically and culturally disparate clinicians, patients and other actors, within and across jurisdictions, in a collaborative manner. EHRI distinguishes between three levels of interoperability, which are potential interoperability, limited connectivity, and extended actual connectivity.

The goals of the EHR IMPACT study required an inductive, empirical approach. Two perspectives were applied, the socio-economic, and a narrower, financial one within the socio-economic. This dual perspective in the EHR IMPACT methodology provides a rigorous evaluation of the long-term impacts of interoperable EHR and ePrescribing systems. The case studies provide empirical insights that underpin findings on the socio-economic impact of interoperable EHR and ePrescribing systems and the factors that need to be in place to accelerate their successful deployment.

Download The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report (.pdf, 581 KB).

Download from the eHealthNews.EU Portal's mirror: The Socio-Economic Impact of Interoperable Electronic Health Record (EHR) and ePrescribing Systems in Europe and Beyond - Final Report (.pdf, 581 KB).

For further information, please visit:
http://www.ehr-impact.eu

Related news articles:

About empirica
empirica Gesellschaft für Kommunikations- und Technologieforschung mbH (empirica) has many years of experience in quantitative and qualitative research methods. Its clients are private companies and public bodies: large and medium-sized companies in the insurance, pharmaceutical and automobile industries as well as software developers and hardware manufacturers. There are also telecommunications service companies and network providers, social services firms, medical facilities, Federal and State Government ministries in Germany and the European Commission as well as the European statistical office (Eurostat). For further information, please visit www.empirica.com.

Most Popular Now

Open Call HORIZON-MISS-2022-CANCER-01-04…

The overall goal of the Mission on Cancer[1] and the Europe's Beating Cancer Plan[2] includes a better quality of life for patients and their families living with, and after, cancer. Project...

Insilico Medicine Raises $60 Million in …

Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that it has completed a $60 million Series D financing from a syndicate of global investors with...

Philips' Future Health Index 2022 Report…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the publication of its Future Health Index (FHI) 2022 report: 'Healthcare hits reset: Priorities shift as...

KTU Researchers Investigate the Links Be…

In recent years Alzheimer's disease has been on the rise throughout the world and is rarely diagnosed at an early stage when it can still be effectively controlled. Using artificial...

Speech Analysis App Predicts Worsening H…

A voice analysis app used by heart failure patients at home recognises fluid in the lungs three weeks before an unplanned hospitalisation or escalation in outpatient drug treatment. The late...

Screening for Diabetic Retinopathy Prove…

Both telemedicine and community screening for diabetic retinopathy (DR) in rural and urban settings are cost-effective in China, and telemedicine screening programs are more cost-effective, according to a study led...

App Detecting Jaundice in Babies a Succe…

A smartphone app that identifies severe jaundice in newborn babies by scanning their eyes could be a life-saver in areas that lack access to expensive screening devices, suggests a study...

Researchers Develop Smartphone-Powered M…

A University of Minnesota Twin Cities research team has developed a new microfluidic chip for diagnosing diseases that uses a minimal number of components and can be powered wirelessly by...

InterSystems Wins Data Driven Product of…

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced it received the prestigious Data Driven Product of the...

Siemens Healthineers Introduces Symbia P…

Siemens Healthineers introduces Symbia Pro.specta™, a single-photon emission computed tomography/computed tomography (SPECT/CT) system with CE Mark and Food and Drug Administration (FDA) clearance that has advanced SPECT and CT imaging...

Oracle Purchase of Cerner Approved

Oracle Corporation (NYSE: ORCL) announced that all required antitrust approvals have been obtained for its proposed acquisition of Cerner, including European Commission clearance. Cerner is a leading provider of digital...